Artificial saliva products and drugs to treat xerostomia.
Wynn
R L
RL
Department of Oral-Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
Meiller
T F
TF
D018678:Cholinergic Agents / Q000627:therapeutic use; D006801:Humans; D018721:Muscarinic Agonists / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D012463:Saliva / Q000187:drug effects / Q000378:metabolism; D012464:Saliva, Artificial / Q000627:therapeutic use*; D012469:Salivary Glands / Q000528:radiation effects; D012859:Sjogren's Syndrome / Q000188:drug therapy; D013876:Thiophenes; D014987:Xerostomia / Q000188:drug therapy* / Q000209:etiology
D018678:Cholinergic Agents; D018721:Muscarinic Agonists; D011812:Quinuclidines; D012464:Saliva, Artificial; D013876:Thiophenes; D010862:Pilocarpine; C059240:cevimeline